Annual EBITDA
-$16.96 M
-$6.12 M-56.47%
31 December 2023
Summary:
Revelation Biosciences annual earnings before interest, taxes, depreciation & amortization is currently -$16.96 million, with the most recent change of -$6.12 million (-56.47%) on 31 December 2023. REVBW annual EBITDA is now -56.47% below its all-time high of -$10.84 million, reached on 31 December 2022.REVBW EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$1.80 M
+$724.09 K+28.74%
30 September 2024
Summary:
Revelation Biosciences quarterly earnings before interest, taxes, depreciation & amortization is currently -$1.80 million, with the most recent change of +$724.09 thousand (+28.74%) on 30 September 2024. Over the past year, it has increased by +$1.07 million (+37.31%). REVBW quarterly EBITDA is now at all-time high.REVBW Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$8.67 M
+$1.07 M+10.98%
30 September 2024
Summary:
Revelation Biosciences TTM earnings before interest, taxes, depreciation & amortization is currently -$8.67 million, with the most recent change of +$1.07 million (+10.98%) on 30 September 2024. Over the past year, it has dropped by -$5.80 million (-202.61%). REVBW TTM EBITDA is now -231.86% below its all-time high of -$2.61 million, reached on 31 March 2021.REVBW TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
REVBW EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -56.5% | +37.3% | -202.6% |
| 3 y3 years | - | +40.9% | -6.8% |
| 5 y5 years | - | - | - |
REVBW EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -56.5% | at low | at high | +72.7% | -202.6% | +45.6% |
| 5 y | 5 years | -56.5% | at low | at high | +72.7% | -231.9% | +45.6% |
| alltime | all time | -56.5% | at low | at high | +72.7% | -231.9% | +45.6% |
Revelation Biosciences EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$1.80 M(-28.7%) | -$8.67 M(-11.0%) |
| June 2024 | - | -$2.52 M(+28.3%) | -$9.74 M(+34.9%) |
| Mar 2024 | - | -$1.96 M(-17.7%) | -$7.22 M(+37.4%) |
| Dec 2023 | -$16.96 M(+56.5%) | -$2.39 M(-16.6%) | -$5.25 M(+83.4%) |
| Sept 2023 | - | -$2.86 M(+54.5%) | -$2.86 M(-81.3%) |
| Dec 2022 | -$10.84 M | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2022 | - | -$1.85 M(-71.8%) | -$15.33 M(-3.8%) |
| Mar 2022 | - | -$6.58 M(+70.7%) | -$15.94 M(+33.2%) |
| Dec 2021 | -$11.93 M | -$3.85 M(+26.9%) | -$11.97 M(+47.5%) |
| Sept 2021 | - | -$3.04 M(+23.2%) | -$8.12 M(+59.8%) |
| June 2021 | - | -$2.47 M(-5.6%) | -$5.08 M(+94.4%) |
| Mar 2021 | - | -$2.61 M | -$2.61 M |
FAQ
- What is Revelation Biosciences annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Revelation Biosciences?
- What is Revelation Biosciences annual EBITDA year-on-year change?
- What is Revelation Biosciences quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Revelation Biosciences?
- What is Revelation Biosciences quarterly EBITDA year-on-year change?
- What is Revelation Biosciences TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Revelation Biosciences?
- What is Revelation Biosciences TTM EBITDA year-on-year change?
What is Revelation Biosciences annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of REVBW is -$16.96 M
What is the all time high annual EBITDA for Revelation Biosciences?
Revelation Biosciences all-time high annual earnings before interest, taxes, depreciation & amortization is -$10.84 M
What is Revelation Biosciences annual EBITDA year-on-year change?
Over the past year, REVBW annual earnings before interest, taxes, depreciation & amortization has changed by -$6.12 M (-56.47%)
What is Revelation Biosciences quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of REVBW is -$1.80 M
What is the all time high quarterly EBITDA for Revelation Biosciences?
Revelation Biosciences all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$1.80 M
What is Revelation Biosciences quarterly EBITDA year-on-year change?
Over the past year, REVBW quarterly earnings before interest, taxes, depreciation & amortization has changed by +$1.07 M (+37.31%)
What is Revelation Biosciences TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of REVBW is -$8.67 M
What is the all time high TTM EBITDA for Revelation Biosciences?
Revelation Biosciences all-time high TTM earnings before interest, taxes, depreciation & amortization is -$2.61 M
What is Revelation Biosciences TTM EBITDA year-on-year change?
Over the past year, REVBW TTM earnings before interest, taxes, depreciation & amortization has changed by -$5.80 M (-202.61%)